<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M654</article-id>
      <article-id pub-id-type="publisher-id">molbank-2010-M654</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>1-[4-[Bis(2-chloroethyl)amino]benzyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one (Cytotoxic Oxonaphthalene-pyrroles, Part II)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Spreitzer</surname>
            <given-names>Helmut</given-names>
          </name>
          <xref rid="c1-molbank-2010-M654" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Puschmann</surname>
            <given-names>Christiane</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2010-M654">Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstra&#xDF;e 14, A- 1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2010-M654"><label>*</label> Author to whom correspondence should be addressed; E-Mail: <email>helmut.spreitzer@univie.ac.at</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>01</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2010</year>
      </pub-date>
      <volume>2010</volume>
      <issue>1</issue>
      <elocation-id>M654</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>01</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>A bis(chloroethyl)amine-containing side chain is attached to an oxonaphthalene-annelated pyrrole in expectation of DNA alkylating properties. The cytotoxicity is evaluated against two cell lines, KB-31 and KB-8511, respectively.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrrole</kwd>
        <kwd>DNA-alkylation</kwd>
        <kwd>anticancer</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Nitrogen mustards were the first clinically effective cancer therapeutic agents. Chlorambucil and melphalan are two of numerous aromatic derivatives of compounds with a nitrogen mustard moiety that have been synthesized. They have been clinical agents for many years and remain in common use at the present time. The cytotoxic effects are based on the highly active aziridinium cation intermediates arising from the bis(2-chloroethyl)amine moiety [<xref ref-type="bibr" rid="B1-molbank-2010-M654">1</xref>]. In continuation of our department&#x2019;s previous studies in the field of antitumor agents [<xref ref-type="bibr" rid="B2-molbank-2010-M654">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2010-M654">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2010-M654">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2010-M654">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2010-M654">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2010-M654">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2010-M654">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2010-M654">9</xref>], we are reporting in this paper the synthesis of the oxonaphthalene-annelated pyrrole <bold>3</bold> with an attached side chain containing a bis(2-chloroethyl)&#xAC;amine group. The cytotoxic activity of <bold>3</bold> was evaluated.</p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>As previously published, <italic>N</italic>-alkylation of <bold>1</bold> [<xref ref-type="bibr" rid="B10-molbank-2010-M654">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2010-M654">11</xref>] with BOC-protected 4-aminobenzyl bromide with NaH in THF selectively afforded <bold>2</bold> [<xref ref-type="bibr" rid="B8-molbank-2010-M654">8</xref>], the following deprotection with trifluoroacetic acid [<xref ref-type="bibr" rid="B12-molbank-2010-M654">12</xref>] furnished the amine which was treated with ethylene oxide [<xref ref-type="bibr" rid="B4-molbank-2010-M654">4</xref>]. The resulting diol was converted <italic>via</italic> its mesylate and subsequent reaction with LiCl [<xref ref-type="bibr" rid="B13-molbank-2010-M654">13</xref>] into the target compound <bold>3</bold>. The biological activity of <bold>3</bold> was tested against two cancer cell lines, KB-31 and KB-8511, respectively. KB-31 is a drug sensitive human epidermoid cell line, whereas KB-8511 is a multi-drug resistant subline, typically over&#xAC;expressing P-glycoprotein. The IC<sub>50</sub>[&#x3BC;M] values of <bold>3</bold> are &gt;2.815 (KB-31) and 2.496 (KB-8511), respectively (for experimental details, see [<xref ref-type="bibr" rid="B14-molbank-2010-M654">14</xref>,<xref ref-type="bibr" rid="B15-molbank-2010-M654">15</xref>]). 
	  <disp-formula id="molbank-2010-M654-i001">
        <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M654-i001.tif"/>
        </disp-formula></p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec id="sec1-molbank-2010-M654">
        <title>1-[4-[Bis(2-chloroethyl)amino]benzyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one <italic><bold>(3)</bold></italic></title>
        <p>(a) To a solution of <bold>2</bold> [<xref ref-type="bibr" rid="B8-molbank-2010-M654">8</xref>] (0.7 g, 1.68 mmol) in 7.7 mL of dry CH<sub>2</sub>Cl<sub>2</sub> were added dropwise under argon 1.53 mL (19.85 mmol) of triflouroacetic acid. After stirring for 2 h at room temperature, the reaction mixture was concentrated under vacuum and the residue was dissolved in ethyl acetate. The organic phase was washed with aqueous NaHCO<sub>3</sub>-solution and brine, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated.</p>
        <p>(b) The resulting crude product was purified by column chromatography (aluminium oxide, light petro&#xAC;leum/ethyl acetate, 60/40) to afford a solid residue which was dissolved in 25 mL of EtOH/H<sub>2</sub>O (3/1). 0.55 mL (0.61 g, 1.40 mmol) of oxirane were added to the reaction mixture at 0 &#xB0;C. After heating for 12 h under reflux, the reaction mixture was concentrated under vacuum and the residue was dissolved in ethyl acetate. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The resulting crude product was used for the next reaction step without further purification. </p>
        <p>(c) To a solution of the obtained crude product in 4.8 mL of dry CH<sub>2</sub>Cl<sub>2</sub> and 0.4 mL of triethylamine were added dropwise under argon 0.20 mL (2.55 mmol) of methanesulfonyl chloride. After stirring for 15 min, the reaction mixture was washed with H<sub>2</sub>O, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under vacuum, The residue was dissolved in 4.5 mL of DMF and, after addition of 0.8 g LiCl (18.90 mmol; dried over P<sub>2</sub>O<sub>5</sub> at 100 &#xB0;C for 12 h), the reaction mixture was heated for 5 min at 120 &#xB0;C. The cooled reaction mixture was diluted with H<sub>2</sub>O and extracted with ethyl acetate. The combined organic layers were washed with H<sub>2</sub>O, dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The crude product was purified by column chromatography (silica gel, light petroleum/ethyl acetate 60/40 + 0.3% TEA) to afford 298 mg (40%) of 3. M.p. 67&#x2013;69 &#xB0;C (light petroleum/ethyl acetate). IR (KBr): 3236, 1644, 1519, 1353, 1179 cm<sup>-1</sup>. MS (EI, 70 eV) <italic>m/z</italic>: 442 (M<sup>+</sup>+2, 14%), 440 (M<sup>+</sup>, 22), 391 (100), 350 (46), 167 (46), 118 (44), 106 (42). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz) &#x3B4; = 9.12 (s<sub>br</sub>, 1H, NH), 7.66 (m, 1H, 9-H), 7.47 (m, 1H, 6-H), 7.34 (d, <italic>J</italic> = 3.0 Hz, 1H, 3-H), 7.22 (m, 2H, 7-H, 8-H), 7.12 (d, <italic>J</italic> = 8.5 Hz, 2H, 2&#x2019;-H, 6&#x2019;-H), 6.62 (d, <italic>J</italic> = 8.5 Hz, 2H, 3&#x2019;-H, 5&#x2019;-H), 4.26 (s, 2H, C-1-<underline>C</underline>H<sub>2</sub>), 3.68 (m, 4H, 2 &#xD7; CH<sub>2</sub>N), 3.59 (m, 4H, 2 &#xD7; CH<sub>2</sub>Cl), 1.51 (s, 6H, (CH<sub>3</sub>)<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 50 MHz) &#x3B4; = 199.8 (C-4), 144.9 (C-4&#x2019;), 144.1 (C-5a), 130.0 (C-2&#x2019;, C-6&#x2019;), 128.4/126.7/125.9 (C-1&#x2019;, C-9a, C-9b), 127.1 (C-6), 126.3 (C-7), 125.9 (C-8), 123.5 (C-9), 119.5/118.7 (C-1, C-3a), 118.98 (C-3), 112.4 (C-3&#x2019;, C-5&#x2019;), 53.4 (2 &#xD7; CH<sub>2</sub>N), 47.8 (C-5), 40.4 (2 &#xD7; CH<sub>2</sub>Cl), 33.0 (<underline>C</underline>H<sub>2</sub>-C-1), 28.2 ((CH<sub>3</sub>)<sub>2</sub>). HRMS calc. for C<sub>25</sub>H<sub>26</sub>N<sub>2</sub>OCl<sub>2</sub>: 440.1422. Found: 440.1417. </p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
    <app id="app1-molbank-2010-M654">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2010-M654-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M654-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2010-M654-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2010-M654-s001.mol">
   <label>Supplementary File 2</label>
   </supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgement</title>
      <p>We are indepted to Novartis AG (Vienna, Austria) for the evaluation of the cytotoxic activity.</p>
    </ack>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2010-M654">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Montgomery</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <source>In Cancer Chemotherapeutic Agents, ACS Pro&#xAC;fessional Reference Book</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Foye</surname>
              <given-names>W.O.</given-names>
            </name>
          </person-group>
          <publisher-name>American Chemical Society</publisher-name>
          <publisher-loc>Washington, DC, USA</publisher-loc>
          <year>1995</year>
          <fpage>111</fpage>
          <lpage>121</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2010-M654">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Carbinol derivatives of azanaphthoquinone annelated pyrrols</article-title>
          <source>Monatsh. Chem.</source>
          <year>2009</year>
          <volume>140</volume>
          <fpage>309</fpage>
          <lpage>313</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-008-0024-3</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2010-M654">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shanab</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pongprom</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wulz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aicher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>G&#xFC;nther</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>6091</fpage>
          <lpage>6095</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.09.054</pub-id>
          <pub-id pub-id-type="pmid">17904839</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2010-M654">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dual function antitumor agents based on bioreduction and DNA-alkylation</article-title>
          <source>Monatsh. Chem.</source>
          <year>2007</year>
          <volume>138</volume>
          <fpage>517</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-007-0604-7</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2010-M654">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sotelo</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>1,5-Dimethyl-6H-pyridazino[4,5-b]carbazole, a 3-Aza bioisoster of the antitumor alkaloid olivacine</article-title>
          <source>Chem. Pharm. Bull.</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>1479</fpage>
          <lpage>1483</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.50.1479</pub-id>
          <pub-id pub-id-type="pmid">12419913</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2010-M654">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kabicher</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Plenk</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and <italic>in-vitro</italic> antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>1900</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="doi">10.3390/12081900</pub-id>
          <pub-id pub-id-type="pmid">17960095</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2010-M654">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jbara</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Traar</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of tetra- and pentacyclic carbazole-fused imides as potential antitumor agents</article-title>
          <source>Arkivoc</source>
          <year>2009</year>
          <fpage>38</fpage>
          <lpage>47</lpage>
        </citation>
      </ref>
      <ref id="B8-molbank-2010-M654">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Regioselective alkylation of an oxonaphthalene-annelated pyrrol system</article-title>
          <source>Molbank</source>
          <year>2009</year>
          <volume>2009</volume>
          <elocation-id>M619</elocation-id>
          <pub-id pub-id-type="doi">10.3390/M619</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2010-M654">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of cytotoxic oxonaphthalene-pyrroles I</article-title>
          <source>Molbank</source>
          <year>2010</year>
		  <volume>2010</volume>
          <elocation-id>M651</elocation-id>
          <pub-id pub-id-type="doi">10.3390/M651</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2010-M654">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pichler</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kogard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tschetschkowitsch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Heinze</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shabaz</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and NMR-investigation of annelated pyrrole derivatives</article-title>
          <source>Heterocycles</source>
          <year>1997</year>
          <volume>45</volume>
          <fpage>1989</fpage>
          <lpage>1997</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-97-7877</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2010-M654">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spreitzer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>F&#xFC;lep</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Puschmann</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-substituted 5,5-dimethyl-2,5-dihydro-4<italic>H</italic>-isoindol-4-ones: Synthesis and NMR-investigation</article-title>
          <source>Heterocycles</source>
          <year>1996</year>
          <volume>43</volume>
          <fpage>1911</fpage>
          <lpage>1922</lpage>
          <pub-id pub-id-type="doi">10.3987/COM-96-7510</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2010-M654">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Cronk</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Dosset</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Hebbel</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Maduskuie</surname>
              <given-names>T.P.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Vacek</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>Y.K.</given-names>
            </name>
            <name>
              <surname>Willard</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Krell</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>D.W.</given-names>
            </name>
          </person-group>
          <article-title>Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes</article-title>
          <source>J. Med. Chem.</source>
          <year>1989</year>
          <volume>32</volume>
          <fpage>807</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00124a014</pub-id>
          <pub-id pub-id-type="pmid">2704027</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2010-M654">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palmer</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>W.R.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>R.F.</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[<italic>N</italic>,<italic>N</italic>-Bis(2-chloroethyl)amino]-2,4-dinitrobenzamide</article-title>
          <source>J. Med. Chem.</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>2518</fpage>
          <lpage>2528</lpage>
          <pub-id pub-id-type="doi">10.1021/jm960057p</pub-id>
          <pub-id pub-id-type="pmid">8691449</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2010-M654">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Regenass</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Fabbro</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Alteri</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>R&#xF6;sel</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Caravatti</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Matter</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and <italic>in vitro</italic> anti-proliferative as well as <italic>in vivo</italic> anti-tumor activity</article-title>
          <source>Int. J. Cancer</source>
          <year>1989</year>
          <volume>43</volume>
          <fpage>851</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.2910430519</pub-id>
          <pub-id pub-id-type="pmid">2714889</pub-id>
        </citation>
      </ref>
      <ref id="B15-molbank-2010-M654">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolaou</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bollbuck</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Werschkun</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Wartmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Altmann</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Guscio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Giannakakou</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Chemical synthesis and biological properties of pyridine epothilones</article-title>
          <source>Chem. Biol.</source>
          <year>2000</year>
          <volume>7</volume>
          <fpage>593</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="doi">10.1016/S1074-5521(00)00006-5</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
